LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Dasatinib | 1.11 | uM | LJP6 | 1 | I03 | 72 | hr | 962 | 1165 | 10693 | 0.1089 | 0.0566 |
MCF 10A | Dasatinib | 1.11 | uM | LJP6 | 2 | I03 | 72 | hr | 962 | 1219 | 10740 | 0.1135 | 0.0703 |
MCF 10A | Dasatinib | 1.11 | uM | LJP6 | 3 | I03 | 72 | hr | 962 | 1433 | 10641 | 0.1347 | 0.1218 |
MCF 10A | Dasatinib | 1.11 | uM | LJP5 | 1 | D03 | 72 | hr | 962 | 1829 | 10714 | 0.1707 | 0.2029 |
MCF 10A | Dasatinib | 1.11 | uM | LJP5 | 2 | D03 | 72 | hr | 962 | 1904 | 10507 | 0.1812 | 0.2188 |
MCF 10A | Dasatinib | 1.11 | uM | LJP5 | 3 | D03 | 72 | hr | 962 | 2037 | 10315 | 0.1975 | 0.2450 |
MCF 10A | Dasatinib | 3.33 | uM | LJP6 | 1 | I02 | 72 | hr | 962 | 904 | 10693 | 0.0845 | -0.0178 |
MCF 10A | Dasatinib | 3.33 | uM | LJP6 | 2 | I02 | 72 | hr | 962 | 893 | 10740 | 0.0831 | -0.0212 |
MCF 10A | Dasatinib | 3.33 | uM | LJP6 | 3 | I02 | 72 | hr | 962 | 1114 | 10641 | 0.1047 | 0.0432 |
MCF 10A | Dasatinib | 3.33 | uM | LJP5 | 1 | D02 | 72 | hr | 962 | 1213 | 10714 | 0.1132 | 0.0689 |
MCF 10A | Dasatinib | 3.33 | uM | LJP5 | 2 | D02 | 72 | hr | 962 | 1097 | 10507 | 0.1044 | 0.0388 |
MCF 10A | Dasatinib | 3.33 | uM | LJP5 | 3 | D02 | 72 | hr | 962 | 1519 | 10315 | 0.1473 | 0.1427 |
MCF 10A | Dasatinib | 10 | uM | LJP6 | 1 | I01 | 72 | hr | 962 | 602 | 10693 | 0.0563 | -0.1263 |
MCF 10A | Dasatinib | 10 | uM | LJP6 | 2 | I01 | 72 | hr | 962 | 451 | 10740 | 0.0420 | -0.1956 |
MCF 10A | Dasatinib | 10 | uM | LJP6 | 3 | I01 | 72 | hr | 962 | 490 | 10641 | 0.0460 | -0.1769 |
MCF 10A | Dasatinib | 10 | uM | LJP5 | 1 | D01 | 72 | hr | 962 | 736 | 10714 | 0.0687 | -0.0742 |
MCF 10A | Dasatinib | 10 | uM | LJP5 | 2 | D01 | 72 | hr | 962 | 847 | 10507 | 0.0806 | -0.0363 |
MCF 10A | Dasatinib | 10 | uM | LJP5 | 3 | D01 | 72 | hr | 962 | 763 | 10315 | 0.0740 | -0.0655 |
MCF 10A | Tozasertib | 0.04 | uM | LJP5 | 1 | B18 | 72 | hr | 962 | 2028 | 10714 | 0.1893 | 0.2392 |
MCF 10A | Tozasertib | 0.04 | uM | LJP5 | 2 | B18 | 72 | hr | 962 | 2026 | 10507 | 0.1928 | 0.2410 |
MCF 10A | Tozasertib | 0.04 | uM | LJP5 | 3 | B18 | 72 | hr | 962 | 2157 | 10315 | 0.2091 | 0.2660 |
MCF 10A | Tozasertib | 0.12 | uM | LJP5 | 1 | B17 | 72 | hr | 962 | 1504 | 10714 | 0.1404 | 0.1371 |
MCF 10A | Tozasertib | 0.12 | uM | LJP5 | 2 | B17 | 72 | hr | 962 | 1485 | 10507 | 0.1413 | 0.1341 |
MCF 10A | Tozasertib | 0.12 | uM | LJP5 | 3 | B17 | 72 | hr | 962 | 1471 | 10315 | 0.1426 | 0.1321 |
MCF 10A | Tozasertib | 0.37 | uM | LJP5 | 1 | B16 | 72 | hr | 962 | 1486 | 10714 | 0.1387 | 0.1332 |